Molecular diagnosis of renal cell neoplasms: the usefulness of immunohistochemistry and fluorescence in situ hybridization

Bibliography

• Amin MB, Tamboli P, Javidan J, et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol 2002;26:281-91
   PubMed Web of Science ®Google Scholar
• Cheville JC, Lohse CM, Zincke H, et al. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 2003;27:612-24
   PubMed Web of Science ®Google Scholar
• Ficarra V, Righetti R, Martignoni G, et al. Prognostic value of renal cell carcinoma nuclear grading: multivariate analysis of 333 cases. Urol Int 2001;67:130-4
   PubMed Web of Science ®Google Scholar
• Moch H, Gasser T, Amin MB, et al. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors. Cancer 2000;89:604-14
   PubMed Web of Science ®Google Scholar
• Delahunt B, Bethwaite PB, Nacey JN. Outcome prediction for renal cell carcinoma: evaluation of prognostic factors for tumours divided according to histological subtype. Pathology 2007;39(5):459-65
   PubMed Web of Science ®Google Scholar
• Eble JN, Sauter G, Epstein JI, Sesterhenn IAE. World Health Organization. Pathology and genetics. Tumours of the urinary system and male genital organs. Lyon: IARC Press; 2004
   Google Scholar
• Martignoni G, Brunelli M, Gobbo S, et al. Role of molecular markers in diagnosis and prognosis of renal cell carcinoma. Anal Quant Cytol Histol 2007;29(1):41-9
   PubMed Web of Science ®Google Scholar
• Jones TD, Eble JN, Cheng L. Application of molecular diagnostic techniques to renal epithelial neoplasms. Clin Lab Med 2005;25:279-303
   PubMed Web of Science ®Google Scholar
• Zhou M, Roma A, Magi-Galluzzi C. The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms. Clin Lab Med 2005;25:247-57
   PubMed Web of Science ®Google Scholar
• Sanjmyatav J, Rubtsov N, Starke H, et al. Identification of tumor entities of renal cell carcinoma using interphase fluorescence in situ hybridization. J Urol 2005;174:731-5
   PubMed Web of Science ®Google Scholar
• Escudier B, Eisen T, Stadler WM, et al. Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 2007;356(2):125-34
   PubMed Web of Science ®Google Scholar
• Avery AK, Beckstead J, Renshaw AA, Corless CL. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am J Surg Pathol 2000;24:203-10
   PubMed Web of Science ®Google Scholar
• Martignoni G, Pea M, Brunelli M, et al. CD10 is expressed in a subset of chromophobe renal cell carcinomas. Mod Pathol 2004;17:1455-63
   PubMed Web of Science ®Google Scholar
• Pan CC, Chen PC, Ho DM. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases. Histopathology 2004;45:452-9
   PubMed Web of Science ®Google Scholar
• Holm-Nielsen P, Pallesen G. Expression of segment-specific antigens in the human nephron and in renal epithelial tumors. APMIS Suppl 1988;4:48-55
   PubMedGoogle Scholar
• Ordonez NG. The diagnostic utility of immunohistochemistry in distinguishing between mesothelioma and renal cell carcinoma: a comparative study. Hum Pathol 2004;35:697-710
   PubMed Web of Science ®Google Scholar
• Rocca PC, Brunelli M, Gobbo S, et al. Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study. Mod Pathol 2007;20(7):722-8
   PubMed Web of Science ®Google Scholar
• Skinnider BF, Folpe AL, Hennigar RA, et al. Distribution of cytokeratins and vimentin in adult renal neoplasms and normal renal tissue: potential utility of a cytokeratin antibody panel in the differential diagnosis of renal tumors. Am J Surg Pathol 2005;29:747-54
   PubMed Web of Science ®Google Scholar
• Kim MK, Kim S. Immunohistochemical profile of common epithelial neoplasms arising in the kidney. Appl Immunohistochem Mol Morphol 2002;10:332-8
   PubMedGoogle Scholar
• Langner C, Wegscheider BJ, Ratschek M, et al. Keratin immunohistochemistry in renal cell carcinoma subtypes and renal oncocytomas: a systematic analysis of 233 tumors. Virchows Arch 2004;444:127-34
   PubMed Web of Science ®Google Scholar
• Tretiakova MS, Sahoo S, Takahashi M, et al. Expression of alpha-methylacyl-CoA racemase in papillary renal cell carcinoma. Am J Surg Pathol 2004;28:69-76
   PubMed Web of Science ®Google Scholar
• Huo L, Sugimura J, Tretiakova MS, et al. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas. Hum Pathol 2005;36:262-8
   PubMed Web of Science ®Google Scholar
• Martignoni G, Pea M, Chilosi M, et al. Parvalbumin is constantly expressed in chromophobe renal carcinoma. Mod Pathol 2001;14:760-7
   PubMed Web of Science ®Google Scholar
• Taki A, Nakatani Y, Misugi K, et al. Chromophobe renal cell carcinoma: an immunohistochemical study of 21 Japanese cases. Mod Pathol 1999;12:310-7
   PubMed Web of Science ®Google Scholar
• Liao SY, Aurelio ON, Jan K, et al. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney. Cancer Res 1997;57:2827-31
   PubMed Web of Science ®Google Scholar
• Sandlund J, Oosterwijk E, Grankvist K, et al. Prognostic impact of carbonic anhydrase IX expression in human renal cell carcinoma. BJU Int 2007;100(3):556-60
   PubMed Web of Science ®Google Scholar
• Tamaskar I, Choueiri TK, Sercia L, et al. Differential expression of caveolin-1 in renal neoplasms. Cancer 2007;110(4):776-82
   PubMed Web of Science ®Google Scholar
• Steiner G, Sidransky D. Molecular differential diagnosis of renal carcinoma: from microscopes to microsatellites. Am J Pathol 1996;149:1791-5
   PubMed Web of Science ®Google Scholar
• Yamaguchi S, Yoshihiro S, Matsuyama H, et al. The allelic loss of chromosome 3p25 with c-myc gain is related to the development of clear-cell renal cell carcinoma. Clin Genet 2003;63(3):184-91
   PubMed Web of Science ®Google Scholar
• Gobbo S, Eble JN, Grignon DJ, et al. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. Am J Surg Pathol 2008; In press
   Google Scholar
• Nagao K, Yoshihiro S, Matsuyama H, et al. Clinical significance of allelic loss of chromosome region 5q22.3 approximately q23.2 in nonpapillary renal cell carcinoma. Cancer Genet Cytogenet 2002;136(1):23-30
   PubMed Web of Science ®Google Scholar
• Herbers J, Schullerus D, Muller H, et al. Significance of chromosome arm 14q loss in nonpapillary renal cell carcinomas. Genes Chromosomes Cancer 1997;19:29-35
   PubMed Web of Science ®Google Scholar
• Brunelli M, Eccher A, Gobbo S, et al. Loss of chromosome 9p is an independent prognostic factor in patients with clear cell renal cell carcinoma. Mod Pathol 2008;21(1):1-6
   PubMed Web of Science ®Google Scholar
• Delahunt B, Eble JN. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol 1997;10:537-44
   PubMed Web of Science ®Google Scholar
• Langner C, Ratschek M, Rehak P, et al. Expression of MUC1 (EMA) and E-cadherin in renal cell carcinoma: a systematic immunohistochemical analysis of 188 cases. Mod Pathol 2004;17:180-8
   PubMed Web of Science ®Google Scholar
• Leroy X, Zini L, Leteurtre E, et al. Morphologic subtyping of papillary renal cell carcinoma: correlation with prognosis and differential expression of MUC1 between the two subtypes. Mod Pathol 2002;15:1126-30
   PubMed Web of Science ®Google Scholar
• Olgac S, Hutchinson B, Tickoo SK, Reuter VE. Alpha-methylacyl-CoA racemase as a marker in the differential diagnosis of metanephric adenoma. Mod Pathol 2006;19:218-24
   PubMed Web of Science ®Google Scholar
• McGregor DK, Khurana KK, Cao C, et al. Diagnosing primary and metastatic renal cell carcinoma: the use of the monoclonal antibody ‘Renal Cell Carcinoma Marker’. Am J Surg Pathol 2001;25:1485-92
   PubMed Web of Science ®Google Scholar
• Brunelli M, Eble JN, Zhang S, et al. Gains of chromosomes 7, 17, 12, 16, and 20 and loss of Y occur early in the evolution of papillary renal cell neoplasia: a fluorescent in situ hybridization study. Mod Pathol 2003;16:1053-9
   PubMed Web of Science ®Google Scholar
• Kunju LP, Wojno K, Wolf JS Jr, et al. Papillary renal cell carcinoma with oncocytic cells and nonoverlapping low grade nuclei: expanding the morphologic spectrum with emphasis on clinicopathologic, immunohistochemical and molecular features. Hum Pathol 2008;39(1):96-101
   PubMed Web of Science ®Google Scholar
• Jiang F, Richter J, Schraml P, et al. Chromosomal imbalances in papillary renal cell carcinoma: genetic differences between histological subtypes. Am J Pathol 1998;153:1467-73
   PubMed Web of Science ®Google Scholar
• Jones TD, Eble JN, Wang M, et al. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas. Clin Cancer Res 2005;11:7226-33
   PubMed Web of Science ®Google Scholar
• Henke RP, Erbersdobler A. Numerical chromosomal aberrations in papillary renal cortical tumors: relationship with histopathologic features. Virchows Arch 2002;440:604-9
   PubMed Web of Science ®Google Scholar
• Hes O, Brunelli M, Michal M, et al. Oncocytic papillary renal cell carcinoma: a clinicopathologic, immunohistochemical, ultrastructural, and interphase cytogenetic study of 12 cases. Ann Diagn Pathol 2006;10(3):133-9
   PubMedGoogle Scholar
• Abrahams NA, MacLennan GT, Khoury JD, et al. Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray. Histopathology 2004;45:593-602
   PubMed Web of Science ®Google Scholar
• Young AN, de Oliveira Salles PG, Lim SD, et al. Beta defensin-1, parvalbumin, and vimentin: a panel of diagnostic immunohistochemical markers for renal tumors derived from gene expression profiling studies using cDNA microarrays. Am J Surg Pathol 2003;27:199-205
   PubMed Web of Science ®Google Scholar
• Hes O, Vanecek T, Perez-Montiel DM, et al. Chromophobe renal cell carcinoma with microcystic and adenomatous arrangement and pigmentation – a diagnostic pitfall. Morphological, immunohistochemical, ultrastructural and molecular genetic report of 20 cases. Virchows Arch 2005;446:383-93
   PubMed Web of Science ®Google Scholar
• Pan CC, Chen PC, Chiang H. Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma. Am J Clin Pathol 2004;121:878-83
   PubMed Web of Science ®Google Scholar
• Yamazaki K, Sakamoto M, Ohta T, et al. Overexpression of KIT in chromophobe renal cell carcinoma. Oncogene 2003;22:847-52
   PubMed Web of Science ®Google Scholar
• Brunelli M, Eble JN, Zhang S, et al. Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10, and 17, and this pattern of genetic abnormality is not present in renal oncocytoma. Mod Pathol 2005;18(2):161-9
   PubMed Web of Science ®Google Scholar
• Iqbal MA, Akhtar M, Ulmer C, et al. FISH analysis in chromophobe renal-cell carcinoma. Diagn Cytopathol 2000;22:3-6
   PubMed Web of Science ®Google Scholar
• Gunawan B, Bergmann F, Braun S, et al. Polyploidization and losses of chromosomes 1, 2, 6, 10, 13, and 17 in three cases of chromophobe renal cell carcinomas. Cancer Genet Cytogenet 1999;110(1):57-61
   PubMed Web of Science ®Google Scholar
• Brunelli M, Gobbo S, Cossu-Rocca P, et al. Chromosomal gains in the sarcomatoid transformation of chromophobe renal cell carcinoma. Mod Pathol 2007;20:303-9
   PubMed Web of Science ®Google Scholar
• Antonelli A, Portesi E, Cozzoli A, et al. The collecting duct carcinoma of the kidney: a cytogenetical study. Eur Urol 2003;43(6):680-5
   PubMed Web of Science ®Google Scholar
• Steiner G, Cairns P, Polascik TJ, et al. High-density mapping of chromosomal arm 1q in renal collecting duct carcinoma: region of minimal deletion at 1q32.1-32.2. Cancer Res 1996;56:5044-6
   PubMed Web of Science ®Google Scholar
• Kruger S, Sotlar K, Kausch I, Horny HP. Expression of KIT (CD117) in renal cell carcinoma and renal oncocytoma. Oncology 2005;68:269-75
   PubMed Web of Science ®Google Scholar
• Hes O, Michal M, Kuroda N, et al. Vimentin reactivity in renal oncocytoma: immunohistochemical study of 234 cases. Arch Pathol Lab Med 2007;131(12):1782-8
   PubMed Web of Science ®Google Scholar
• Leroy X, Moukassa D, Copin MC, et al. Utility of cytokeratin 7 for distinguishing chromophobe renal cell carcinoma from renal oncocytoma. Eur Urol 2000;37:484-7
   PubMed Web of Science ®Google Scholar
• Mathers ME, Pollock AM, Marsh C, O'Donnell M. Cytokeratin 7: a useful adjunct in the diagnosis of chromophobe renal cell carcinoma. Histopathology 2002;40:563-7
   PubMed Web of Science ®Google Scholar
• Patton KT, Tretiakova MS, Yao JL, et al. Expression of RON proto-oncogene in renal oncocytoma and chromophobe renal cell carcinoma. Am J Surg Pathol 2004;28:1045-50
   PubMed Web of Science ®Google Scholar
• Rampino T, Gregorini M, Soccio G, et al. The Ron proto-oncogene product is a phenotypic marker of renal oncocytoma. Am J Surg Pathol 2003;27:779-85
   PubMed Web of Science ®Google Scholar
• Li G, Barthelemy A, Feng G, et al. S100A1: a powerful marker to differentiate chromophobe renal cell carcinoma from renal oncocytoma. Histopathology 2007;50:642-7
   PubMed Web of Science ®Google Scholar
• Fuzesi L, Frank D, Nguyen C, et al. Losses of 1p and chromosome 14 in renal oncocytomas. Cancer Genet Cytogenet 2005;160:120-5
   PubMed Web of Science ®Google Scholar
• Lindgren V, Paner GP, Omeroglu A, et al. Cytogenetic analysis of a series of 13 renal oncocytomas. J Urol 2004;171:602-4
   PubMed Web of Science ®Google Scholar
• Paner GP, Lindgren V, Jacobson K, et al. High incidence of chromosome 1 abnormalities in a series of 27 renal oncocytomas: cytogenetic and fluorescence in situ hybridization studies. Arch Pathol Lab Med 2007;131(1):81-5
   PubMed Web of Science ®Google Scholar
• Muir TE, Cheville JC, Lager DJ. Metanephric adenoma, nephrogenic rests, and Wilms' tumor: a histologic and immunophenotypic comparison. Am J Surg Pathol 2001;25:1290-6
   PubMed Web of Science ®Google Scholar
• Brunelli M, Eble JN, Zhang S, et al. Metanephric adenoma lacks the gains of chromosomes 7 and 17 and loss of Y that are typical of papillary renal cell carcinoma and papillary adenoma. Mod Pathol 2003;16:1060-3
   PubMed Web of Science ®Google Scholar
• Renshaw AA, Freyer DR, Hammers YA. Metastatic metanephric adenoma in a child. Am J Surg Pathol 2000;24:570-4
   PubMed Web of Science ®Google Scholar
• Renshaw AA, Maurici D, Fletcher JA. Cytologic and fluorescence in situ hybridization (FISH) examination of metanephric adenoma. Diagn Cytopathol 1997;16:107-11
   PubMed Web of Science ®Google Scholar
• Eble JN. Mucinous tubular and spindle cell carcinoma and post-neuroblastoma carcinoma: newly recognised entities in the renal cell carcinoma family. Pathology 2003;35:499-504
   PubMed Web of Science ®Google Scholar
• Ferlicot S, Allory Y, Comperat E, et al. Mucinous tubular and spindle cell carcinoma: a report of 15 cases and a review of the literature. Virchows Arch 2005;447:978-83
   PubMed Web of Science ®Google Scholar
• Paner GP, Srigley JR, Radhakrishnan A, et al. Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney: significant immunophenotypic overlap warrants diagnostic caution. Am J Surg Pathol 2006;30:13-9
   PubMed Web of Science ®Google Scholar
• Cossu-Rocca P, Eble JN, Delahunt B, et al. Renal mucinous tubular and spindle carcinoma lacks the gains of chromosomes 7 and 17 and losses of chromosome Y that are prevalent in papillary renal cell carcinoma. Mod Pathol 2006;19:488-93
   PubMed Web of Science ®Google Scholar
• Srigley J. Mucinous tubular and spindle cell carcinoma. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA, editors, World Health Organization. Classification of tumours: pathology and genetics of tumours of the urinary system and male genital organs. Lyon: IARC Press; 2004. p. 40
   Google Scholar
• Argani P, Antonescu CR, Couturier J, et al. PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21). Am J Surg Pathol 2002;26:1553-66
   PubMed Web of Science ®Google Scholar
• Argani P, Antonescu CR, Illei PB, et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol 2001;159:179-92
   PubMed Web of Science ®Google Scholar
• Argani P, Lal P, Hutchinson B, et al. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol 2003;27:750-61
   PubMed Web of Science ®Google Scholar
• Argani P, Hawkins A, Griffin CA, et al. A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocation. Am J Pathol 2001;158:2089-96
   PubMed Web of Science ®Google Scholar
• Davis IJ, Hsi BL, Arroyo JD, et al. Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation. Proc Natl Acad Sci USA 2003;100:6051-6
   PubMed Web of Science ®Google Scholar
• Kuiper RP, Schepens M, Thijssen J, et al. Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution. Hum Mol Genet 2003;12:1661-9
   PubMed Web of Science ®Google Scholar
• Kuiper RP, Schepens M, Thijssen J, et al. Regulation of the MiTF/TFE bHLH-LZ transcription factors through restricted spatial expression and alternative splicing of functional domains. Nucleic Acids Res 2004;32(8):2315-22
   PubMed Web of Science ®Google Scholar
• Argani P, Lae M, Hutchinson B, et al. Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR. Am J Surg Pathol 2005;29:230-40
   PubMed Web of Science ®Google Scholar
• Pecciarini L, Cangi MG, Lo Cunsolo C, et al. Characterization of t(6;11)(p21;q12) in a renal-cell carcinoma of an adult patient. Genes Chromosomes Cancer 2007;46(5):419-26
   PubMed Web of Science ®Google Scholar
• Tickoo SK, dePeralta-Venturina MN, Harik LR, et al. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 2006;30:141-53
   PubMed Web of Science ®Google Scholar
• Cossu-Rocca P, Eble JN, Zhang S, et al. Acquired cystic disease-associated renal tumors: an immunohistochemical and fluorescence in situ hybridization study. Mod Pathol 2006;19:780-7
   PubMed Web of Science ®Google Scholar
• O'Reilly KC, Tickoo SK, Amin MB, et al. Renal cell tumors arising in end stage renal disease (ESRD): a karyotypic study with fluorescent-in situ-hybridization (FISH). Mod Pathol 2005;18:156A
   Google Scholar
• Begin LR, Guy L, Jacobson SA, Aprikian AG. Renal carcinoid and horseshoe kidney: a frequent association of two rare entities – a case report and review of the literature. J Surg Oncol 1998;68:113-9
   PubMed Web of Science ®Google Scholar
• Shurtleff BT, Shvarts O, Rajfer J. Carcinoid tumor of the kidney: case report and review of the literature. Rev Urol 2005;7(4):229-33
   PubMedGoogle Scholar
• van den Berg E, Gouw AS, Oosterhuis JW, et al. Carcinoid in a horseshoe kidney. Morphology, immunohistochemistry, and cytogenetics. Cancer Genet Cytogenet 1995;845:95
   Google Scholar
• Lane BR, Chery F, Jour G, et al. Renal neuroendocrine tumours: a clinicopathological study. BJU Int 2007;100(5):1030-5
   PubMed Web of Science ®Google Scholar
• Bonetti F, Pea M, Martignoni G, et al. Clear cell (“sugar”) tumor of the lung is a lesion strictly related to angiomyolipoma – the concept of a family of lesions characterized by the presence of the perivascular epithelioid cells (PEC). Pathology 1994;26:230-6
   PubMed Web of Science ®Google Scholar
• Martignoni G, Pea M, Bonetti F, et al. Carcinoma-like monotypic epithelioid angiomyolipoma in patients without evidence of tuberous sclerosis: a clinicopathologic and genetic study. Am J Surg Pathol 1998;22:663-72
   PubMed Web of Science ®Google Scholar
• Pea M, Bonetti F, Martignoni G, et al. Apparent renal cell carcinomas in tuberous sclerosis are heterogeneous: the identification of malignant epithelioid angiomyolipoma. Am J Surg Pathol 1998;22:180-7
   PubMed Web of Science ®Google Scholar
• Pea M, Bonetti F, Zamboni G, et al. Melanocyte-marker-HMB-45 is regularly expressed in angiomyolipoma of the kidney. Pathology 1991;23:185-8
   PubMed Web of Science ®Google Scholar
• Pan CC, Jong YJ, Chai CY, et al. Comparative genomic hybridization study of perivascular epithelioid cell tumor: molecular genetic evidence of perivascular epithelioid cell tumor as a distinctive neoplasm. Hum Pathol 2006;37(5):606-12
   PubMed Web of Science ®Google Scholar
• Martignoni G, Pea M, Bonetti F, et al. Oncocytoma-like angiomyolipoma. A clinicopathologic and immunohistochemical study of 2 cases. Arch Pathol Lab Med 2002;126:610-2
   PubMed Web of Science ®Google Scholar
• Martignoni G, Pea M, Rigaud G, et al. Renal angiomyolipoma with epithelioid sarcomatous transformation and metastases: demonstration of the same genetic defects in the primary and metastatic lesions. Am J Surg Pathol 2000;24:889-94
   PubMed Web of Science ®Google Scholar
• Gobbo S, Eble JN, Huang J, et al. Schwannoma of the Kidney. Mod Pathol 2008; In press
   Google Scholar
• Kuroda N, Inoue Y, Taguchi T, et al. Renal leiomyoma: an immunohistochemical, ultrastructural and comparative genomic hybridization study. Histol Histopathol 2007;22(8):883-8
   PubMed Web of Science ®Google Scholar
• Deyrup AT, Montgomery E, Fisher C. Leiomyosarcoma of the kidney: a clinicopathologic study. Am J Surg Pathol 2004;28:178-82
   PubMed Web of Science ®Google Scholar
• Clifford SC, Maher ER. Von Hippel-Lindau disease: clinical and molecular perspectives. Adv Cancer Res 2001;82:85-105
   PubMed Web of Science ®Google Scholar
• Zbar B, Glenn G, Lubensky I, et al. Hereditary papillary renal cell carcinoma: clinical studies in 10 families. J Urol 1995;153:907-12
   PubMed Web of Science ®Google Scholar
• Kaelin WG Jr. The von Hippel-Lindau tumor suppressor gene and kidney cancer. Clin Cancer Res 2004;10(18 Pt 2):6290S-6295S
   PubMed Web of Science ®Google Scholar
• Linehan WM, Walther MM, Zbar B. The genetic basis of cancer of the kidney. J Urol 2003;170:2163-72
   PubMed Web of Science ®Google Scholar
• Thoma CR, Frew IJ, Hoerner CR, et al. pVHL and GSK3beta are components of a primary cilium-maintenance signalling network. Nat Cell Biol 2007;9(5):588-95
   PubMed Web of Science ®Google Scholar
• Schmidt L, Duh FM, Chen F, et al. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 1997;16:68-73
   PubMed Web of Science ®Google Scholar
• Zhuang Z, Park WS, Pack S, et al. Trisomy 7-harbouring non-random duplication of the mutant Met allele in hereditary papillary renal carcinomas. Nat Genet 1998;20:66-9
   PubMed Web of Science ®Google Scholar
• Alam NA, Olpin S, Rowan A, et al. Missense mutations in fumarate hydratase in multiple cutaneous and uterine leiomyomatosis and renal cell cancer. J Mol Diagn 2005;7(4):437-43
   PubMed Web of Science ®Google Scholar
• Chan I, Wong T, Martinez-Mir A, et al. Familial multiple cutaneous and uterine leiomyomas associated with papillary renal cell cancer. Clin Exp Dermatol 2005;30(1):75-8
   PubMed Web of Science ®Google Scholar
• Stewart L, Glenn G, Toro JR. Cutaneous leiomyomas: a clinical marker of risk for hereditary leiomyomatosis and renal cell cancer. Dermatol Nurs 2006;18(4):335-41; quiz 42
   PubMedGoogle Scholar
• Birt AR, Hogg GR, Dubè WJ. Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons. Arch Dermatol 1977;113(12):1674-7
   PubMed Web of Science ®Google Scholar
• Pavlovich CP, Walther MM, Eyler RA, et al. Renal tumors in the Birt-Hogg-Dubè syndrome. Am J Surg Pathol 2002;26:1542-52
   PubMed Web of Science ®Google Scholar
• Tickoo SK, Reuter VE, Amin MB, et al. Renal oncocytosis: a morphologic study of fourteen cases. Am J Surg Pathol 1999;23:1094-101
   PubMed Web of Science ®Google Scholar
• Khoo SK, Kahnoski K, Sugimura J, et al. Inactivation of BHD in sporadic renal tumors. Cancer Res 2003;63:4583-7
   PubMed Web of Science ®Google Scholar
• Warren MB, Torres-Cabala CA, Turner ML, et al. Expression of Birt-Hogg-Dubè gene mRNA in normal and neoplastic human tissues. Mod Pathol 2004;17(8):998-1011
   PubMed Web of Science ®Google Scholar
• Al-Saleem T, Cairns P, Dulaimi EA, et al. The genetics of renal oncocytosis: a possible model for neoplastic progression. Cancer Genet Cytogenet 2004;152:23-8
   PubMed Web of Science ®Google Scholar
• Cossu-Rocca P, Eble JN, Zhang S, et al. Interphase cytogenetic analysis with centromeric probes for chromosomes 1, 2, 6, 10, and 17 in 11 tumors from a patient with bilateral renal oncocytosis. Mod Pathol 2008;21(4):498-504
   PubMed Web of Science ®Google Scholar
• Bissig H, Richter J, Desper R, et al. Evaluation of the clonal relationship between primary and metastatic renal cell carcinoma by comparative genomic hybridization. Am J Pathol 1999;155(1):267-74
   PubMed Web of Science ®Google Scholar
• Gronwald J, Storkel S, Holtgreve-Grez H, et al. Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events. Cancer Res 1997;57(3):481-7
   PubMed Web of Science ®Google Scholar
• Junker K, Moravek P, Podhola M, et al. Genetic alterations in metastatic renal cell carcinoma detected by comparative genomic hybridization: correlation with clinical and histological data. Int J Oncol 2000;17(5):903-8
   PubMed Web of Science ®Google Scholar
• Junker K, Romics I, Szendroi A, et al. Genetic profile of bone metastases in renal cell carcinoma. Eur Urol 2004;45(3):320-4
   PubMed Web of Science ®Google Scholar
• Junker K, Sanger J, Schmidt A, et al. Genetic characterization of lung metastases in renal cell carcinoma. Oncol Rep 2003;10(4):1035-8
   PubMed Web of Science ®Google Scholar